Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$4,779,461
+$4,148,806 QoQ
Shares Held
18,819
+629.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#1,653
of 4,676 holders
Holding Since
Dec 2022
4 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Western Financial Corp/CA holds $8,064,519 across 7 Drug Manufacturers - General names. JNJ ranks #1 (59.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
18,819 | $4,779,461 | |
| 2 | MRK |
Merck & Co., Inc.
|
5,469 | $702,766 | |
| 3 | AMGN |
Amgen Inc
|
1,902 | $688,752 | |
| 4 | LLY |
ELI LILLY & Co
|
513 | $615,307 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,860 | $614,012 | |
| 6 | PFE |
Pfizer Inc
|
14,678 | $353,446 | |
| 7 | ABBV |
AbbVie Inc.
|
1,235 | $310,775 |
All Filings in JNJ
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,779,461 | 18,819 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $630,655 | 2,580 | Shares | Sole | 2026-04-23 | |
| 2023-03-31 | $237,925 | 1,535 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $971,221 | 5,498 | Shares | Sole | 2023-01-20 | |
| No filing history on record for this holder in this stock. | ||||||